Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.44% |
| 2 | Technology | 18.54% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Zillow
Z
$8.33B
| $504K | ﹤0.01% |
15,964
-28,497
| -64% | -$1.01M |
|
1777
Melco Resorts & Entertainment
MLCO
$2.08B
| $502K | ﹤0.01% |
28,502
-5,096
| -15% | -$90.8K |
|
1778
Tactile Systems Technology
TCMD
$529M
| $501K | ﹤0.01% |
10,988
-10,149
| -48% | -$585K |
|
1779
Otter Tail
OTTR
$3.86B
| $500K | ﹤0.01% |
10,078
-226
| -2% | -$10.8K |
|
1780
Supernus Pharmaceuticals
SUPN
$2.62B
| $500K | ﹤0.01% |
15,049
-17,617
| -54% | -$758K |
|
1781
Fate Therapeutics
FATE
$292M
| $498K | ﹤0.01% |
38,814
-8,393
| -18% | -$117K |
|
1782
Kinder Morgan
KMI
$69B
| $497K | ﹤0.01% |
+32,310
| New | +$547K |
|
1783
Acadia Realty Trust
AKR
$2.93B
| $496K | ﹤0.01% |
20,855
+150
| +0.7% | +$4.13K |
|
1784
Cenovus Energy
CVE
$59.3B
| $496K | ﹤0.01% |
70,563
-474,908
| -87% | -$3.91M |
|
1785
NMI Holdings
NMIH
$3.42B
| $495K | ﹤0.01% |
27,739
-5,639
| -17% | -$110K |
|
1786
AGNC Investment
AGNC
$13B
| $494K | ﹤0.01% |
28,159
-57,505
| -67% | -$1.02M |
|
|
CVGW
1787
DELISTED
Calavo Growers
CVGW
| $493K | ﹤0.01% |
6,761
+101
| +2% | +$9.44K |
|
1788
Guidewire Software
GWRE
$16B
| $492K | ﹤0.01% |
6,135
-2,056
| -25% | -$179K |
|
1789
Viavi Solutions
VIAV
$9.12B
| $492K | ﹤0.01% |
+48,942
| New | +$528K |
|
1790
Gorman-Rupp
GRC
$2.06B
| $489K | ﹤0.01% |
15,088
-23,585
| -61% | -$788K |
|
1791
Cars.com
CARS
$662M
| $480K | ﹤0.01% |
22,315
-79,200
| -78% | -$1.98M |
|
|
JBGS
1792
JBG SMITH
JBGS
$732M
| $479K | ﹤0.01% |
13,757
-4,370
| -24% | -$164K |
|
|
DPLO
1793
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $479K | ﹤0.01% |
35,578
-29,498
| -45% | -$497K |
|
|
SYNH
1794
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $477K | ﹤0.01% |
+12,123
| New | +$563K |
|
1795
Sprouts Farmers Market
SFM
$8.03B
| $476K | ﹤0.01% |
+20,240
| New | +$527K |
|
1796
FMC
FMC
$1.41B
| $475K | ﹤0.01% |
7,406
+350
| +5% | +$24.5K |
|
|
SGEN
1797
DELISTED
Seagen Inc. Common Stock
SGEN
| $475K | ﹤0.01% |
8,385
-8,147
| -49% | -$511K |
|
|
TSG
1798
DELISTED
The Stars Group Inc.
TSG
| $474K | ﹤0.01% |
28,723
-149,502
| -84% | -$2.92M |
|
1799
Washington Trust Bancorp
WASH
$758M
| $473K | ﹤0.01% |
9,959
-3,630
| -27% | -$187K |
|
|
AYR
1800
DELISTED
Aircastle Ltd
AYR
| $473K | ﹤0.01% |
27,458
+13,507
| +97% | +$257K |
|
Similar funds
Cliff Asness's Q4 2018 Portfolio in Review
As of Q4 2018, Cliff Asness held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cliff Asness's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- Cliff Asness added most to Merck in Q4 2018, an estimated $354M increase.
- Cliff Asness's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- Cliff Asness fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- Cliff Asness's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- Cliff Asness opened 138 new positions and closed 217 in Q4 2018.
- Cliff Asness's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.